UA94054C2 - Nitrocatechol derivatives as comt inhibitors - Google Patents

Nitrocatechol derivatives as comt inhibitors

Info

Publication number
UA94054C2
UA94054C2 UAA200802153A UAA200802153A UA94054C2 UA 94054 C2 UA94054 C2 UA 94054C2 UA A200802153 A UAA200802153 A UA A200802153A UA A200802153 A UAA200802153 A UA A200802153A UA 94054 C2 UA94054 C2 UA 94054C2
Authority
UA
Ukraine
Prior art keywords
comt inhibitors
nitrocatechol derivatives
nitrocatechol
derivatives
compounds
Prior art date
Application number
UAA200802153A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Дейвид Александер Лермонт
Ласло Эрно КИСС
Палма Педро Нуно Лил
Сантос Феррейра Умберто Дос
Соарес Да Силва Патрисио Мануэль Виэйра Араужо
Original Assignee
Портела Энд Ка. С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Портела Энд Ка. С.А. filed Critical Портела Энд Ка. С.А.
Publication of UA94054C2 publication Critical patent/UA94054C2/en

Links

Abstract

New compounds of formula I are described. The compounds have potentially valuable pharmaceutical properties in the treatment of some central and peripheral nervous system disorders.
UAA200802153A 2005-07-26 2006-07-26 Nitrocatechol derivatives as comt inhibitors UA94054C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0515327A GB0515327D0 (en) 2005-07-26 2005-07-26 Comt inhibitors

Publications (1)

Publication Number Publication Date
UA94054C2 true UA94054C2 (en) 2011-04-11

Family

ID=34976612

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200802153A UA94054C2 (en) 2005-07-26 2006-07-26 Nitrocatechol derivatives as comt inhibitors

Country Status (4)

Country Link
CN (1) CN101248064B (en)
GB (1) GB0515327D0 (en)
UA (1) UA94054C2 (en)
ZA (1) ZA200800672B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2481410T (en) * 2007-01-31 2016-10-18 BIAL-PORTELA & Cª S A Nitrocatechol derivates as comt inhibitors administered with a specific dosage regime
PT2542084T (en) * 2010-03-04 2018-03-23 Merck Sharp & Dohme Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders
CN107935953A (en) * 2017-12-31 2018-04-20 佛山市赛维斯医药科技有限公司 COMT inhibitor, preparation method and its usage containing terminal olefinic link and hydrazide structure
CN108148004A (en) * 2017-12-31 2018-06-12 佛山市赛维斯医药科技有限公司 The compound of a kind of hydrazine containing propionyl and pyrimidine structure, preparation method and its usage
CN108218796A (en) * 2017-12-31 2018-06-29 佛山市赛维斯医药科技有限公司 Compound, preparation method and its usage containing hydrazide structure
CN108191775A (en) * 2017-12-31 2018-06-22 佛山市赛维斯医药科技有限公司 A kind of terminal allylic propionyl hydrazine structural compounds and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363792A (en) * 2000-06-21 2002-01-09 Portela & Ca Sa Nitrocatechols
GB0015228D0 (en) * 2000-06-21 2000-08-16 Portela & Ca Sa Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders

Also Published As

Publication number Publication date
CN101248064A (en) 2008-08-20
GB0515327D0 (en) 2005-08-31
CN101248064B (en) 2012-07-04
ZA200800672B (en) 2009-01-28

Similar Documents

Publication Publication Date Title
CY1116754T1 (en) NITROCATECHOL PRODUCTS AS COMT INHIBITORS
IL184898A0 (en) Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same
PT1902037E (en) 2,4-diamino-pyrimidines used as aurora inhibitors
MX2009006535A (en) Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors.
MX2008005398A (en) 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer.
TW200734327A (en) Aminopyrimidines useful as kinase inhibitors
TW200740803A (en) Heterocyclic derivatives as modulators of ion channels
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
TW200724537A (en) Pyrimidine derivatives for treatment of hyperproliferative disorders
MXPA06011327A (en) Azaindoles useful as inhibitors of jak and other protein kinases.
MX2009010037A (en) Aminopyrimidines useful as kinase inhibitors.
MY149957A (en) Heterocyclic inhibitors of mek and methods of use thereof
IL200793A0 (en) Aminopyrimidines, compositions comprising the same and use thereof for inhibiting protein kinases
IL181987A0 (en) Diaminotriazole derivatives and pharmaceutical compositions containing the same
WO2006123113A3 (en) Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
IL196543A (en) Pyridazinone derivatives and pharmaceutical compositions comprising them for use in the treatment of disorders
EA025871B9 (en) Mek inhibitors and methods of using the same
MX2010003866A (en) Heteroaryl amides useful as inhibitors of voltage-gated sodium channels.
MX2009011811A (en) Aminopyrimidines useful as kinase inhibitors.
IL181700A0 (en) Quinazoline derivatives and pharmaceutical compositions containing the same
MX2009010127A (en) N-heterocyclic compounds useful as inhibitors of janus kinases.
IL205696A0 (en) Heterocyclic derivatives, compositions comprising the same and uses thereof
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
UA87494C2 (en) Azaindoles useful as inhibitors of jak and other protein kinases
TW200801018A (en) 6,6-bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors